These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15459465)

  • 1. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction.
    Nakagawa K; Umetani K; Fujioka D; Sano K; Nakamura T; Kodama Y; Kitta Y; Ichigi Y; Kawabata K; Obata JE; Takano H; Inobe Y; Kugiyama K
    Circ J; 2004 Oct; 68(10):923-7. PubMed ID: 15459465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography.
    Ceriani L; Giovanella L
    Clin Chem Lab Med; 2007; 45(2):226-31. PubMed ID: 17311513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction.
    Marumoto K; Hamada M; Aburaya M; Hiwada K
    Jpn Circ J; 1995 Nov; 59(11):715-24. PubMed ID: 8747761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction.
    Klemola R; Tikkanen I; Vuolteenaho O; Toivonen L; Laine M
    Eur J Heart Fail; 2001 Jan; 3(1):21-6. PubMed ID: 11163731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.
    Darbar D; Davidson NC; Gillespie N; Choy AM; Lang CC; Shyr Y; McNeill GP; Pringle TH; Struthers AD
    Am J Cardiol; 1996 Aug; 78(3):284-7. PubMed ID: 8759805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
    Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma B-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction.
    Niu JM; Ma ZL; Xie C; Zhang ZQ
    Genet Mol Res; 2014 Feb; 13(3):6177-83. PubMed ID: 24634292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of left ventricular diastolic function on the secretion of B-type natriuretic peptide at rest and directly after exercise test in asymptomatic patients with diabetes or after myocardial infarction with preserved left ventricular systolic functi.
    Stępień-Wałek A; Wożakowska-Kapłon B
    Kardiol Pol; 2016; 74(6):529-36. PubMed ID: 26575310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain natriuretic peptide and cardiac rupture after acute myocardial infarction.
    Arakawa N; Nakamura M; Endo H; Sugawara S; Suzuki T; Hiramori K
    Intern Med; 2001 Mar; 40(3):232-6. PubMed ID: 11310490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
    Mazurek W; Salomon P
    Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of brain natriuretic peptide after acute myocardial infarction.
    Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.